Skip to content

Effect of Ketamine for pediatrics pain

Efficacy and safety of oral low dose ketamine for pediatric Intravenous cannulation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201504251764N3
Enrollment
70
Registered
2015-07-06
Start date
2014-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain during Intravenous placement in pediatrics.

Interventions

Intervention 1: After obtaining consent from the parents of patients , patients are classified in two groups of intervention and control by permuted block randomization . Then for each group a questio
Treatment - Drugs
Placebo
After obtaining consent from the parents of patients , patients are classified in two groups of intervention and control by permuted block randomization . Then for each group a questionnaire includin
After obtaining consent from the parents of patients , patients are classified in two groups of intervention and control by permuted block randomization . then for each group a questionnaire including

Sponsors

Vice chancellor for research,Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children with no pain at baseline will enter the study? also children take part in the study who are able to take the drug orally. Exclusion criteria: having any medical condition in which procedure is emergent and there is no 20-30 minutes chance to take analgesic; having any contraindication for prescribing ketamine (included but not limited to high blood pressure; high intracranial pressure; high intraocular pressure; Heart failure; Thyroid diseases; Respiratory system instability); the history of taking ketamine by patient in the last 24 hour in this center (in this study); 4. American Society of Anesthesiologists class= III; abnormal neurological exam; lack of parental consent; having any condition that makes evaluating pain difficult; Glasgow Coma Scale less than 15.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain while Intravenous placement in pediatrics. Timepoint: 30 minutes after taking oral Ketamine. Method of measurement: Measurement of pain in children ; pain score(Children's Hospital of Eastern Ontario Pain Scale, Visual Analog Scale).;Cooperation during catheter insertion. Timepoint: 30 minutes after taking the oral ketamine. Method of measurement: I.V Sedation Scale.

Secondary

MeasureTime frame
Potential side effects due to use of oral ketamine. Timepoint: first 1 hour and 24 hours after taking of oral ketamine. Method of measurement: Checklist of side effects of ketamine.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahdi Bagheri

Tehran University of Medical Sciences

m_mbagheri1367@yahoo.com+98 21 3605 4188

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026